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Abstract 
Crohn’s disease (CD) is a chronic inflammatory disorder affecting the gastrointestinal (GI) tract. Although the GI 
tract is the primary site of involvement, many patients, particularly in pediatric cases, first present with non-intesti-
nal manifestations, including oral lesions. Oral manifestations of CD in children occur in around 50-80% of cases, 
and about 30% of CD cases in children occur first in the mouth. Recognizing such oral lesions in the pediatric po-
pulation, and requesting a biopsy, may expedite the diagnosis of CD.  We describe a 15 year old male who presented 
with oral findings of multiple aphthous ulcers and plaques of pink papules of the buccal vestibule. We highlight 
the initial pathology findings, including non-caseating granulomas, sialadenitis, and a notable plasmacytosis, from 
biopsy of the left retromolar pad area, which triggered further testing for CD. We provide discussion of how CD 
was eventually diagnosed and treated and highlight the significance of the pathological findings in this case as they 
relate to the pathogenesis of CD.
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Introduction
Inflammatory Bowel Diseases (IBD) which include 
Crohn’s disease (CD) and ulcerative colitis (UC) are 
chronic and disabling diseases with a high and increa-
sing incidence across continents (1). CD is an immune 
mediated chronic inflammatory disorder characterized 
by granulomatous inflammation that can occur from the 
oral cavity to the anus (2). Approximately 50-80% of 
pediatric patients with CD have oral changes including 
multiple superficial ulcers (aphthous ulcers) and cob-
blestone appearing pink papules on the buccal mucosa 
and vestibule (3). Of those, in more than 30%-60%, the 
oral findings may be the first manifestation of CD (3,4). 
In the pediatric population, failure to consider CD on the 
differential diagnosis of persistent multiple oral ulcers 
and other oral findings can delay necessary care for pa-
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tients (3). We describe a 15 year old male who presented 
with multiple persistent oral ulcers and papules which 
were found to be the first manifestation of CD. We pre-
sent this case with review of current literature pertaining 
to oral CD in pediatric patients. This case also offers an 
interesting pathology finding, highlighting the immuno-
logic nature of the disease. Consistent with almost all 
cases of CD, non-caseating granulomas were found and 
were the trigger for further testing for CD; in this case, 
however, there was also a collection of monotypic plas-
ma cells in the oral biopsy. 
Case Report
A 15-year old Caucasian male initially presented to his 
family practice physician with palpable bilateral cer-
vical lymph nodes. The enlargement of the nodes was 
interpreted to be of viral association and was treated 
conservatively. Approximately one month later, the pa-
tient developed episodic oral pain while eating which 
evolved into gingival bleeding, cheek swelling, and was 
associated with development of generalized superficial 
ulcers with clustering in the posterior soft palate and the 
vestibules. The patient also developed confluent flesh-
colored papules in the bilateral posterior vestibule, buc-
cal mucosa, and retromolar pad areas of his mouth (Fig. 
1 A,B). He was referred to an Otolaryngologist who 
started the patient on a 10 day course of antibiotics and 
referred the patient to an oral surgeon for an incisional 
Fig. 1: (A,B) Multiple small and superficial ulcers (yellow arrows) with white centers and red halos in the posterior 
soft palate of the patient’s oral cavity. Plaques of pink papules are present in the posterior buccal mucosa and bilat-
eral retromolar areas. (C,D) Biopsy of the left retromolar pad area demonstrates mucosal ulceration with discrete 
non-caseating granulomas and plasmacytosis with patchy infiltrates of monotypic kappa light chain plasma cells.
biopsy. Following results of the incisional biopsy of the 
left retromolar pad, the patient was next referred to Gas-
troenterology and underwent endoscopy and colonosco-
py. Additional history obtained by the Gastroenterologist 
prior to endoscopic evaluation was significant for a ten 
pound weight loss over approximately one year associa-
ted with intermittent right-sided abdominal discomfort 
and episodes of blood on the toilet paper. The patient’s 
family history is notable for Crohn’s disease in a pater-
nal grandmother, lymphocytic colitis in a paternal aunt, 
and ulcerative colitis in a paternal great-grandfather. 
Fecal calprotectin prior to endoscopy was 477 mcg/g. 
Rheumatoid factor was normal. Erythrocyte sedimentation 
rate was 18 mm/hr. C-reactive protein was 13 mg/L. Serum 
protein electrophoresis demonstrated a broad gamma in-
crease, with a non-specific pattern and no monoclonal pro-
teins. Quantiferon gold test was negative for tuberculosis.
As requested by the oral surgeon, biopsy of the left retro-
molar pad area was performed. 
Histologic sections demonstrated mucosal ulceration 
with discrete non-caseating granulomas, sialadenitis, 
and plasmacytosis with patchy infiltrates of monotypic 
kappa restricted light chain plasma cells (Fig. 1C,D). 
Testing for Epstein-Barr Virus was negative as well as 
fungal, mycobacterial, and spirochete special stains. A 
diagnosis of non-caseating granulomatous inflammation 
was rendered with a comment mentioning Crohn’s di-
sease as a possible etiology.
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On subsequent examination by endoscopy, the upper gas-
trointestinal tract was notable for mild patchy erythema 
in the duodenum. The entire colon demonstrated scatte-
red areas of mildly erythematous mucosa and multiple 
aphthous ulcers similar to those noted in the oral cavity. 
Multiple biopsies were taken. The terminal ileum contai-
ned a patchy area of mucosa that was mildly erythema-
tous. Scattered white exudates and mucosal hemorrha-
ges were appreciated and, again, multiple biopsies were 
taken. The perianal and digital rectal examinations were 
normal (Fig. 2 A,B). MRI enterography demonstrated no 
radiographic evidence of bowel inflammation.  
Biopsies taken at the time of endoscopy were remarka-
ble for mild to moderate chronic active inflammation 
with multifocal discrete non-caseating granulomas in 
both the upper and lower gastrointestinal tract similar 
to those of the oral cavity lesions. The stomach and co-
lon had multifocal discrete granulomas (Fig. 2C,D). The 
esophagus and duodenum were more mildly affected. 
The terminal ileum had focal prominent surface infiltra-
tion by neutrophils with underlying granulation changes 
and subtotal villous architecture atrophy. 
The differential diagnosis for this patient’s clinical 
presentation included CD, infectious diseases (fungal, 
mycobacterial, spirochetes), drug-induced reactions, 
response to foreign body, nutritional deficiencies, and 
rheumatological disease. A variety of infectious or drug-
related conditions have been shown to clinically mimic 
Fig. 2: (A,B) Areas of mildly erythematous mucosa and multiple aphthous ulcers with scattered areas of white exu-
dates and mucosal hemorrhages in the colon, similar to those noted in the oral cavity. (C) Biopsy of gastric mucosa 
with non-caseating granuloma. (D) Right colon with diffuse acute and chronic inflammation, reactive injury, and 
multiple non-discrete granulomas (yellow arrows).
CD, although those etiologies often present more acu-
tely. Granulomas can occur in infectious diseases inclu-
ding tuberculosis and Yersinia pseudotuberculosis. 
Based on results of the oral biopsy, endoscopic evalua-
tion and associated biopsies, and laboratory values, a 
diagnosis of Crohn’s disease was rendered. After discus-
sion with the patient and family, the decision was made 
to start both corticosteroids and enteral nutritional the-
rapy, with 80% of daily calories from an intact protein 
formula (5). The patient and family were interested in 
considering nutritional therapy long-term. The patient 
began a steroid wean and has not had recurrence of 
oral lesions or gastrointestinal symptoms. The decision 
to start maintenance immunosuppressive therapy was 
made six weeks after diagnosis as the family decided 
that primary nutritional therapy would be difficult to 
maintain long-term.  
Discussion
Crohn’s disease is a chronic inflammatory bowel disease 
believed to involve interplay of genetic, immunologic, 
and environmental factors. It commonly begins gradua-
lly, but may also start abruptly. Two age peaks in occu-
rrence are described: one among early adulthood and the 
other in patients over 60 years of age (6,7). Children and 
adolescents with CD often have more extensive disease 
with a more severe disease course than adults. Although 
the GI tract is the primary site of involvement in CD, 
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many cases, particularly in pediatric patients, first pre-
sent with non-intestinal manifestations, including oral 
lesions. Younger pediatric patients often also present 
with weight loss, delayed growth, or failure to thrive. As 
with the patient presented here, younger age at diagnosis 
(younger than 20 years) is associated with greater preva-
lence of a family history of CD (8).
Studies have shown that oral manifestations of CD in 
children occur in around 50%-80% of cases, and about 
30% of CD cases in children occur first in the mouth (3). 
One study suggested as high as 60% of cases of pedia-
tric CD have oral symptoms as the first presenting sign 
of the disease (9). Oral lesions can precede, occur con-
currently, or follow the onset of abdominal symptoms, 
although synchronous observation is most commonly 
described. Failure to include IBD, particularly CD, on 
the differential for oral manifestations can lead to delay 
in diagnosis and treatment for patients or extensive un-
necessary workups. 
The most common sites for clinical presentation of oral 
lesions in CD are the lips, gingiva, vestibular sulci and 
buccal mucosa (9). Mucogingivitis occurs in about 25% 
of cases, followed by multiple and persistent superficial 
oral ulcers simulating minor aphthous ulcers, which oc-
cur in about 8% of the cases (10). Cobblestone papules 
of the buccal mucosa and vestibule occur in about 6% 
of the patients (10). These findings may be associated 
with pain, impairment of oral function, and psychosocial 
stress (9). Other non-specific oral findings of CD include 
angular cheilitis, persistent submandibular lymphadeno-
pathy, gingivitis, and periodontal disease (4,11). 
The first step in treating oral lesions is to assess for, and 
control, intestinal disease (4). It is also important to form 
a complete differential diagnosis for the oral manifes-
tations, including side effects of drugs, nutritional de-
ficiencies, infections and other granulomatous diseases 
with oral involvement (4). If the oral findings are as-
ymptomatic, no particular treatment for the oral lesions 
is necessary and they will resolve over time in associa-
tion with the treatment of gastrointestinal disease. The 
diagnosis of CD is ultimately made by a combination 
of clinical, laboratory, radiographic, and endoscopic ob-
servations. The clinical course of CD is characterized 
by exacerbation and spontaneous, medication, or dietary 
therapy induced remission. General treatments include 
sulfa-type drugs, i.e. sulfasalazine; dietary therapy, or 
immunosuppressive agents such as systemic steroids, 
azathioprine, methotrexate, or anti-TNF-alpha antibo-
dies. 
While the exact causes of Crohn’s disease remain unk-
nown, some studies have postulated that changes in the 
immune system and exposure to environmental risk 
factors, including responses to gastrointestinal bacteria, 
may be triggers of CD (12). Dysregulation of various 
components of the immune system can be seen in the gut 
of patients with CD. This dysregulation is thought to be 
sustained by increased local proinflammatory cytokine 
products and by defects in counter-regulatory mecha-
nisms (13). 
In this patient’s case, the histological suggestion of CD 
was largely based on the finding of the non-caseating 
granulomas. The occurrence of focal inflammation si-
multaneous with severe patchy inflammation in the 
set of biopsies also gave a significant discriminative 
value in favor of CD. In a study of patients with oral 
CD, non-caseating granulomas were found in 100% of 
the oral biopsy specimens taken from the oral lesions, 
highlighting the value of the easily accessible oral mu-
cosa as a potential site for harvesting diagnostic mate-
rial, especially in pediatric patients (10). 
This case also presented a notable finding of predomi-
nantly monotypic, kappa restricted, plasma cells infil-
trating the biopsy tissue. While in CD the gut is known 
to be massively infiltrated with B cells and plasma cells, 
the plasma cells are usually polyclonal. The role of the 
plasma cells in the pathogenesis of gut tissue damage is 
largely unknown. In CD, plasma cells have been shown 
to produce non-organ-specific antibodies, which might 
contribute to complement deposition and destruction 
of gastrointestinal epithelial cells (14,15). It is always 
a concern when plasma cells appear to be monotypic, 
giving the impression of a neoplastic cell proliferation 
such as a plasma cell neoplasm or lymphoid neoplasm 
with plasmacytic differentiation; however, the age of the 
patient made these diseases highly unlikely. Additiona-
lly, malignant lymphomas with plasmablastic differen-
tiation of the mouth might also be included on the di-
fferential, but are more commonly described in immune 
compromised patients.  
In conclusion, we describe a 15 year old male with 
persistent multiple oral aphthous ulcers and plaques of 
pink papules of the buccal vestibule that were the first 
manifestation of CD. Recognizing such oral lesions in 
the pediatric population and requesting a biopsy of the 
accessible papules and/or the superficial ulcers may help 
expedite the diagnosis of CD.  
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